Cigna Group (CI) stock
CINYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3021% below fair value
$301.45−1.68 (-0.55%)
Close on Nov 11, 2026Market cap $79.66BP/E 13.3Yield 2.00%
Cigna cash
Cash and short-term investments held at the end of each period.
Cigna's cash was $7.30B at Sep 30, 2026. For fiscal 2025 it was $8.73B, up 6.3% from the year before. Over ten years it grew 16.1% a year on average. The highest annual figure on record is $11.58B in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.73B | +6.3% |
| FY2024 | Dec 31, 2024 | $8.22B | -6.6% |
| FY2023 | Dec 31, 2023 | $8.80B | +27.8% |
| FY2022 | Dec 31, 2022 | $6.88B | +13.9% |
| FY2021 | Dec 31, 2021 | $6.04B | -47.8% |
| FY2020 | Dec 31, 2020 | $11.58B | +106.5% |
| FY2019 | Dec 31, 2019 | $5.61B | -5.0% |
| FY2018 | Dec 31, 2018 | $5.90B | +15.5% |
| FY2017 | Dec 31, 2017 | $5.11B | +60.4% |
| FY2016 | Dec 31, 2016 | $3.19B | +61.8% |
| FY2015 | Dec 31, 2015 | $1.97B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.30B | +4.9% |
| Q2 FY2026 | Jun 30, 2026 | $7.26B | +39.6% |
| Q1 FY2026 | Mar 31, 2026 | $7.85B | -13.7% |
| Q4 FY2025 | Dec 31, 2025 | $8.73B | +6.3% |
| Q3 FY2025 | Sep 30, 2025 | $6.95B | +2.3% |
| Q2 FY2025 | Jun 30, 2025 | $5.20B | -34.2% |
| Q1 FY2025 | Mar 31, 2025 | $9.10B | -5.1% |
| Q4 FY2024 | Dec 31, 2024 | $8.22B | -6.6% |
| Q3 FY2024 | Sep 30, 2024 | $6.80B | -29.1% |
| Q2 FY2024 | Jun 30, 2024 | $7.90B | -24.8% |
| Q1 FY2024 | Mar 31, 2024 | $9.59B | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $8.80B | +27.8% |
| Q3 FY2023 | Sep 30, 2023 | $9.59B | +21.4% |
| Q2 FY2023 | Jun 30, 2023 | $10.51B | +101.2% |
| Q1 FY2023 | Mar 31, 2023 | $8.90B | +71.2% |
| Q4 FY2022 | Dec 31, 2022 | $6.88B | +13.9% |
| Q3 FY2022 | Sep 30, 2022 | $7.90B | +60.8% |
| Q2 FY2022 | Jun 30, 2022 | $5.22B | +0.8% |
| Q1 FY2022 | Mar 31, 2022 | $5.20B | -35.2% |
| Q4 FY2021 | Dec 31, 2021 | $6.04B | -47.8% |
| Q3 FY2021 | Sep 30, 2021 | $4.91B | -27.0% |
| Q2 FY2021 | Jun 30, 2021 | $5.18B | -38.1% |
| Q1 FY2021 | Mar 31, 2021 | $8.02B | +47.9% |
| Q4 FY2020 | Dec 31, 2020 | $11.58B | +106.5% |
| Q3 FY2020 | Sep 30, 2020 | $6.73B | +13.1% |
| Q2 FY2020 | Jun 30, 2020 | $8.38B | +58.8% |
| Q1 FY2020 | Mar 31, 2020 | $5.43B | -18.3% |
| Q4 FY2019 | Dec 31, 2019 | $5.61B | -5.0% |
| Q3 FY2019 | Sep 30, 2019 | $5.95B | -75.2% |
| Q2 FY2019 | Jun 30, 2019 | $5.28B | +45.2% |
| Q1 FY2019 | Mar 31, 2019 | $6.64B | +139.6% |
| Q4 FY2018 | Dec 31, 2018 | $5.90B | +15.5% |
| Q3 FY2018 | Sep 30, 2018 | $24.03B | +654.5% |
| Q2 FY2018 | Jun 30, 2018 | $3.63B | – |
| Q1 FY2018 | Mar 31, 2018 | $2.77B | – |
| Q4 FY2017 | Dec 31, 2017 | $5.11B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.19B | – |
See a number that looks wrong?